GGrantIndex
← Leaderboards

Christopher A Ross

Johns Hopkins University

Google Scholar ↗PubMed ↗ORCID ↗
$35,771,871
Attributed
$50,713,184
Total exposure
30
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.7M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$66,835,386 · 32

By mechanism

R01$26,141,041 · 8
P01$12,671,323 · 3
U01$9,393,228 · 2
P50$6,710,796 · 4
T32$5,417,988 · 1
RC2$3,776,244 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Neurons”

Research focus

NeuronsCellsPathogenesisBrainHuntington DiseaseToxic EffectGenesProteinsPhenotypeMutantNeurodegenerative DisordersMutationIn VitroGeneticCag RepeatCell ModelNerve DegenerationMouse ModelCorpus Striatum StructureTissuesFutureNeuropathologySeriesIn Vivo

Grant awards (132)

Tools for gene editing in marmosets$2,165,656
U01 · FY2025 · DA
LRRK2 and inflammasome pathway in Parkinson's disease$609,816
R01 · FY2025 · NS
Tools for gene editing in marmosets$1,955,019
U01 · FY2024 · DA
LRRK2 and inflammasome pathway in Parkinson's disease$607,790
R01 · FY2024 · NS
Tools for gene editing in marmosets$2,195,576
U01 · FY2023 · DA
LRRK2 and inflammasome pathway in Parkinson's disease$642,851
R01 · FY2023 · NS
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease$573,811
R01 · FY2023 · NS · contact PI
Tools for gene editing in marmosets$163,748
U01 · FY2023 · DA
Tools for gene editing in marmosets$1,798,234
U01 · FY2022 · DA
LRRK2 and inflammasome pathway in Parkinson's disease$658,627
R01 · FY2022 · NS
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease$612,838
R01 · FY2022 · NS · contact PI
Immortalized Striatal Precursor Neurons as a Screenable Model of HD$409,375
R33 · FY2022 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$326,067
T32 · FY2022 · MH · contact PI
LRRK2 and inflammasome pathway in Parkinson's disease$673,122
R01 · FY2021 · NS
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease$628,597
R01 · FY2021 · NS · contact PI
Tracing Spread of Pathology Within The HD Brain via Automated Neuroimaging$599,142
R01 · FY2021 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$350,046
T32 · FY2021 · MH · contact PI
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease$639,103
R01 · FY2020 · NS · contact PI
Tracing Spread of Pathology Within The HD Brain via Automated Neuroimaging$599,917
R01 · FY2020 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$371,557
T32 · FY2020 · MH · contact PI
Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease$639,103
R01 · FY2019 · NS · contact PI
Tracing Spread of Pathology Within The HD Brain via Automated Neuroimaging$600,678
R01 · FY2019 · NS
Immortalized Striatal Precursor Neurons as a Screenable Model of HD$398,887
R21 · FY2019 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$338,979
T32 · FY2019 · MH · contact PI
2019 CAG Triplets Repeat Disorders GRC/GRS$20,000
R13 · FY2019 · NS · contact PI
Tracing Spread of Pathology Within The HD Brain via Automated Neuroimaging$628,012
R01 · FY2018 · NS
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)$613,121
R01 · FY2018 · NS · contact PI
Immortalized Striatal Precursor Neurons as a Screenable Model of HD$403,537
R21 · FY2018 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$253,835
T32 · FY2018 · MH · contact PI
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)$615,717
R01 · FY2017 · NS · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$589,943
R01 · FY2017 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$324,783
T32 · FY2017 · MH · contact PI
2017 CAG Triplet Repeat Disorders Gordon Research Conference and Gordon Research Seminar$15,000
R13 · FY2017 · NS · contact PI
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)$626,506
R01 · FY2016 · NS · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$606,057
R01 · FY2016 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$313,554
T32 · FY2016 · MH · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$674,688
R01 · FY2015 · NS
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)$626,506
R01 · FY2015 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$255,858
T32 · FY2015 · MH · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$681,033
R01 · FY2014 · NS
Validation of Novel Pathogenic Htt Post-Translational Modifications (PTMs)$626,506
R01 · FY2014 · NS · contact PI
Immortalized Human Strital Precursors as a Cell Model of HD$200,475
R21 · FY2014 · NS · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$653,528
R01 · FY2013 · NS
Basal Ganglia Shape Analysis and Circuitry in Huntington's Disease$536,616
U01 · FY2013 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$273,032
T32 · FY2013 · MH · contact PI
Immortalized Human Strital Precursors as a Cell Model of HD$243,000
R21 · FY2013 · NS · contact PI
Basal Ganglia Shape Analysis and Circuitry in Huntington's Disease$578,379
U01 · FY2012 · NS
Interdisciplinary Training in Psychiatry and Neuroscience$299,784
T32 · FY2012 · MH · contact PI
LRRK2 and Parkinson's Disease Cell Biology$351,575
R01 · FY2011 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$256,075
T32 · FY2011 · MH · contact PI
Parkinson's Disease Mouse Model with Mutant LRRK2$200,900
R21 · FY2011 · NS · contact PI
Research Center Without Walls for Huntington's Disease$162,000
P50 · FY2011 · NS · contact PI
The Huntington's Disease iPS Consortium$1,839,894
RC2 · FY2010 · NS
Research Center Without Walls for Huntington's Disease$1,334,475
P50 · FY2010 · NS · contact PI
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials$1,221,991
R01 · FY2010 · NS · contact PI
LRRK2 and Parkinson's Disease Cell Biology$355,163
R01 · FY2010 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$252,701
T32 · FY2010 · MH · contact PI
Parkinson's Disease Mouse Model with Mutant LRRK2$246,000
R21 · FY2010 · NS · contact PI
Translating Natural Products into Therapeutic Leads for Huntington's Disease$188,325
R21 · FY2010 · NS
Clinical progression and pathologic correlates of Huntington's disease$99,477
P50 · FY2010 · NS · contact PI
Research Center Without Walls for Huntington's Disease$82,000
P50 · FY2010 · NS · contact PI
The Huntington's Disease iPS Consortium$76,500
RC2 · FY2010 · NS
The Huntington's Disease iPS Consortium$1,859,850
RC2 · FY2009 · NS
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials$1,351,314
R01 · FY2009 · NS · contact PI
Research Center Without Walls for Huntington's Disease$1,334,699
P50 · FY2009 · NS · contact PI
LRRK2 and Parkinson's Disease Cell Biology$358,750
R01 · FY2009 · NS · contact PI
Interdisciplinary Training in Psychiatry and Neuroscience$230,945
T32 · FY2009 · MH · contact PI
Translating Natural Products into Therapeutic Leads for Huntington's Disease$226,345
R21 · FY2009 · NS
Clinical progression and pathologic correlates of Huntington's disease$93,737
P50 · FY2009 · NS · contact PI
HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING$15,584
P41 · FY2009 · RR · contact PI
Research Center Without Walls for Huntington's Disease$1,334,828
P50 · FY2008 · NS · contact PI
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials$1,182,774
R01 · FY2008 · NS · contact PI
PD Cell Models: Alpha-Synuclein and Interacting Proteins$387,247
P50 · FY2008 · NS · contact PI
LRRK2 and Parkinson's Disease Cell Biology$358,750
R01 · FY2008 · NS · contact PI
Interdisciplinary Training in Psychiatry & Neuroscience$218,420
T32 · FY2008 · MH · contact PI
Clinical progression and pathologic correlates of Huntington's disease$93,726
P50 · FY2008 · NS · contact PI
HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING$9,756
P41 · FY2008 · RR · contact PI
Research Center Without Walls for Huntington's Disease$1,374,283
P01 · FY2007 · NS · contact PI
PD Cell Models: Alpha-Synuclein and Interacting Proteins$387,056
P50 · FY2007 · NS · contact PI
Neurodegeneration and Polyglutamine Toxicity DRPLA$368,191
R01 · FY2007 · NS · contact PI
LRRK2 and Parkinson's Disease Cell Biology$358,750
R01 · FY2007 · NS · contact PI
Interdisciplinary Training in Psychiatry & Neuroscience$214,021
T32 · FY2007 · MH · contact PI
Clinical progression and pathologic correlates of Huntington's disease$106,168
P01 · FY2007 · NS · contact PI
STUDIES OF HUNTINGTON'S DISEASE$1,913
M01 · FY2007 · RR · contact PI
Research Center Without Walls for Huntington's Disease$1,443,477
P01 · FY2006 · NS · contact PI
Neurodegeneration and Polyglutamine Toxicity DRPLA$379,188
R01 · FY2006 · NS · contact PI
Transgenic Models of Huntington's Disease$369,209
R01 · FY2006 · NS · contact PI
PD Cell Models: Alpha-Synuclein and Interacting Proteins$341,499
P50 · FY2006 · NS · contact PI
Interdisciplinary Training in Psychiatry & Neuroscience$117,886
T32 · FY2006 · MH · contact PI
Clinical progression and pathologic correlates of Huntington's disease$93,641
P01 · FY2006 · NS · contact PI
STUDIES OF HUNGTINGTON'S DISEASE$7,809
M01 · FY2006 · RR · contact PI
Research Center Without Walls for Huntington's Disease$1,544,120
P01 · FY2005 · NS
Neurodegeneration and Polyglutamine Toxicity DRPLA$388,313
R01 · FY2005 · NS
Transgenic Models of Huntington's Disease$378,094
R01 · FY2005 · NS
PD Cell Models: Alpha-Synuclein and Interacting Proteins$331,552
P50 · FY2005 · NS
Interdisciplinary Training in Psychiatry &Neuroscience$208,432
T32 · FY2005 · MH
CELL BIOLOGY OF THE HD GENE PROTEIN PRODUCT$73,467
P01 · FY2005 · NS
STUDIES OF HUNGTINGTON'S DISEASE$10,966
M01 · FY2005 · RR
Research Center Without Walls for Huntington's Disease$1,546,133
P01 · FY2004 · NS
Neurodegeneration and Polyglutamine Toxicity DRPLA$388,313
R01 · FY2004 · NS
Transgenic Models of Huntington's Disease$378,094
R01 · FY2004 · NS
PD Cell Models: Alpha-Synuclein and Interacting Proteins$321,896
P50 · FY2004 · NS
Interdisciplinary Training in Psychiatry &Neuroscience$169,497
T32 · FY2004 · MH
Studies of Hungtington's Disease$6,894
M01 · FY2004 · RR
Research Center Without Walls for Huntington's Disease$1,536,283
P01 · FY2003 · NS
Neurodegeneration and Polyglutamine Toxicity DRPLA$388,313
R01 · FY2003 · NS
Transgenic Models of Huntington's Disease$378,094
R01 · FY2003 · NS
INTERDISCIPLINARY TRAINING IN PSYCHIATRY &NEUROSCIENCE$184,396
T32 · FY2003 · MH
SYNPHILIN 1--MOLECULAR MECHANISMS OF PARKINSON'S DISEASE$40,000
R03 · FY2003 · TW
Research Center Without Walls for Huntington's Disease$1,526,132
P01 · FY2002 · NS
TRANSGENIC MODELS OF HUNTINGTONS DISEASE$375,859
R01 · FY2002 · NS
NEURODEGENERATION AND GENES WITH TRIPLET REPEATS$374,701
R01 · FY2002 · NS
INTERDISCIPLINARY TRAINING IN PSYCHIATRY &NEUROSCIENCE$196,803
T32 · FY2002 · MH
ALPHA-SYNUCLEIN AND INTERACTING PROTEINS--IN VITRO STUDIES$88,647
P50 · FY2002 · NS
CELL BIOLOGY OF THE HD GENE PROTEIN PRODUCT$73,467
P01 · FY2002 · NS
SYNPHILIN 1--MOLECULAR MECHANISMS OF PARKINSON'S DISEASE$40,000
R03 · FY2002 · TW
Research Center Without Walls for Huntington's Disease$1,543,772
P01 · FY2001 · NS
NEURODEGENERATION AND GENES WITH TRIPLET REPEATS$365,414
R01 · FY2001 · NS
TRANSGENIC MODELS OF HUNTINGTONS DISEASE$354,074
R01 · FY2001 · NS
INTERDISCIPLINARY TRAINING IN PSYCHIATRY &NEUROSCIENCE$173,023
T32 · FY2001 · MH
MOLECULAR PATHOLOGY OF HUNTINGTON'S DISEASE$172,411
P01 · FY2001 · NS
Research Center Without Walls for Huntington's Disease$100,000
P01 · FY2001 · NS
ALPHA-SYNUCLEIN AND INTERACTING PROTEINS--IN VITRO STUDIES$88,647
P50 · FY2001 · NS
CELL BIOLOGY OF THE HD GENE PROTEIN PRODUCT$73,467
P01 · FY2001 · NS
SYNPHILIN 1--MOLECULAR MECHANISMS OF PARKINSON'S DISEASE$40,000
R03 · FY2001 · TW
ALPHA-SYNUCLEIN AND INTERACTING PROTEINS--IN VITRO STUDIES$0
P50 · FY2001 · NS
RESEARCH PROGRAM WITHOUT WALLS FOR HUNTINGTONS DISEASE$1,260,000
P01 · FY2000 · NS
NEURODEGENERATION AND GENES WITH TRIPLET REPEATS$356,274
R01 · FY2000 · NS
TRANSGENIC MODELS OF HUNTINGTONS DISEASE$332,831
R01 · FY2000 · NS
ALPHA-SYNUCLEIN AND INTERACTING PROTEINS--IN VITRO STUDIES$229,310
P50 · FY2000 · NS
CELL BIOLOGY OF THE HD GENE PROTEIN PRODUCT$204,502
P01 · FY2000 · NS
INTERDISCIPLINARY TRAINING IN PSYCHIATRY &NEUROSCIENCE$88,294
T32 · FY2000 · MH